| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 50 |
| 1 | METHOTREXATE SODIUM | 41 |
| 2 | OMEPRAZOLE MAGNESIUM | 40 |
| 3 | METHOTREXATE | 38 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 32 |
| 5 | OMEPRAZOLE | 30 |
| 6 | ASPIRIN | 22 |
| 7 | ETANERCEPT | 21 |
| 8 | ASPIRIN 325 MG | 20 |
| 9 | ASPIRIN 81 MG | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 2 | 0.0022 |
| 1 | RIPRETINIB | 6 | 0.0011 |
| 2 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 3 | NITISINONE | 1 | 0.0010 |
| 4 | CLINDAMYCIN PHOSPHATE | 5 | 0.0009 |
| 5 | VINORELBINE | 6 | 0.0009 |
| 6 | ERDAFITINIB | 1 | 0.0008 |
| 7 | GOLIMUMAB | 9 | 0.0007 |
| 8 | ADO-TRASTUZUMAB EMTANSINE | 6 | 0.0007 |
| 9 | ERGOCALCIFEROL | 18 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 48 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 4 | Corticosteroid [EPC] | 35 |
| 5 | Kinase Inhibitor [EPC] | 33 |
| 6 | Benzodiazepine [EPC] | 24 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 23 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 23 |
| 9 | Factor Xa Inhibitor [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 4 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 6 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 7 | Antiparasitic [EPC] | 1 | 0.0002 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 3 | 0.0002 |
| 9 | Pediculicide [EPC] | 1 | 0.0002 |